113 related articles for article (PubMed ID: 38453104)
1. A kidney-targeted chitosan-melanin nanoplatform for alleviating diabetic nephropathy through modulation of blood glucose and oxidative stress.
Sun J; Han J; Dong J; Zhai X; Zhang R
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130663. PubMed ID: 38453104
[TBL] [Abstract][Full Text] [Related]
2. An auto-photoacoustic melanin-based drug delivery nano-platform for self-monitoring of acute kidney injury therapy via a triple-collaborative strategy.
Zhao X; Sun J; Dong J; Guo C; Cai W; Han J; Shen H; Lv S; Zhang R
Acta Biomater; 2022 Jul; 147():327-341. PubMed ID: 35643195
[TBL] [Abstract][Full Text] [Related]
3. Alleviative effects of 20(R)-Rg3 on HFD/STZ-induced diabetic nephropathy via MAPK/NF-κB signaling pathways in C57BL/6 mice.
Li Y; Hou JG; Liu Z; Gong XJ; Hu JN; Wang YP; Liu WC; Lin XH; Wang Z; Li W
J Ethnopharmacol; 2021 Mar; 267():113500. PubMed ID: 33091499
[TBL] [Abstract][Full Text] [Related]
4. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
[TBL] [Abstract][Full Text] [Related]
5. CD44-targeted melanin-based nanoplatform for alleviation of ischemia/reperfusion-induced acute kidney injury.
Sun J; Zhao X; Shen H; Dong J; Rong S; Cai W; Zhang R
J Control Release; 2024 Apr; 368():1-14. PubMed ID: 38367863
[TBL] [Abstract][Full Text] [Related]
6. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
An ZM; Dong XG; Guo Y; Zhou JL; Qin T
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):356-361. PubMed ID: 26072073
[TBL] [Abstract][Full Text] [Related]
7. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
8. Pyrroloquinoline Quinone Inhibits Oxidative Stress in Rats with Diabetic Nephropathy.
Zhang M; Zhang J; Xiong Y; Peng J; Wu X
Med Sci Monit; 2020 Jun; 26():e924372. PubMed ID: 32592386
[TBL] [Abstract][Full Text] [Related]
9. Nephroprotective potential of syringic acid in experimental diabetic nephropathy: Focus on oxidative stress and autophagy.
Sherkhane B; Yerra VG; Sharma A; Kumar KA; Chayanika G; Kumar AV; Kumar A
Indian J Pharmacol; 2023; 55(1):34-42. PubMed ID: 36960519
[TBL] [Abstract][Full Text] [Related]
10. A ROS-scavenging multifunctional nanoparticle for combinational therapy of diabetic nephropathy.
Tong Y; Zhang L; Gong R; Shi J; Zhong L; Duan X; Zhu Y
Nanoscale; 2020 Dec; 12(46):23607-23619. PubMed ID: 33210670
[TBL] [Abstract][Full Text] [Related]
11. The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro.
Zhang W; Miao J; Wang S; Zhang Y
PLoS One; 2013; 8(5):e63472. PubMed ID: 23658831
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-interacting protein: a potential therapeutic target for treatment of progressive fibrosis in diabetic nephropathy.
Tan CY; Weier Q; Zhang Y; Cox AJ; Kelly DJ; Langham RG
Nephron; 2015; 129(2):109-27. PubMed ID: 25662516
[TBL] [Abstract][Full Text] [Related]
14. Nucleoporin 160 (NUP160) inhibition alleviates diabetic nephropathy by activating autophagy.
Xie J; Yuan Y; Yao G; Chen Z; Yu W; Zhu Q
Bioengineered; 2021 Dec; 12(1):6390-6402. PubMed ID: 34533106
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
16. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
17. A proteoglycan isolated from Ganoderma lucidum attenuates diabetic kidney disease by inhibiting oxidative stress-induced renal fibrosis both in vitro and in vivo.
Pan Y; Zhang Y; Li J; Zhang Z; He Y; Zhao Q; Yang H; Zhou P
J Ethnopharmacol; 2023 Jun; 310():116405. PubMed ID: 36966849
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic value of melatonin in diabetic nephropathy: improvement beyond anti-oxidative stress.
Guo C; He J; Deng X; Wang D; Yuan G
Arch Physiol Biochem; 2023 Dec; 129(6):1250-1261. PubMed ID: 34048666
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
